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Abstract 
Background: To study the effect of Nicotinic acid 
(Niacin) on body weight in NZW rabbits on atherogenic 
diet. 
Methods: In this experimental study, forty adult male 
New Zealand White (NZW) rabbits were randomly 
assigned to four groups A, B, C and D, each comprising ten 
rabbits. Group A served as Pure Control and received 
standard animal house diet (concentrated diet). Group B as 
treated control was given atherogenic diet (concentrated 
diet + 0.5% cholesterol), Group C as an experimental group 
was given Niacin in a dose of 15mg/kg b.w mixed in 
atherogenic diet (concentrated diet + 0.5% cholesterol) for 
two months. Group D served as an experimental group 
received atherogenic diet (concentrated diet + 0.5% 
cholesterol) for two months then was shifted to standard 
animal house diet (concentrated diet) mixed with Niacin in 
a dose of 15mg/kg b.w. Rabbits were weighed at the 
beginning of the experiment and then before their 
sacrifice.   
Results: - The mean initial body weight (Wi)of rabbits 
in group A,B,C and D was 1.875±0.094, 1.670±0.067, 
1.660±0.085 and 1.805±0.038 kg respectively. The mean final 
body weight(Wf) of rabbits was 1.850±0.099, 1.920±0.046, 
1.695±0.069 and 1.745±0.052 kg respectively. ANOVA 
showed significant (p<0.05) difference in mean values of 
body weight among the groups. Post Hoc test using Least 
Significant Difference (LSD) showed significant 
difference (p<0.05), when weight change was compared 
among the groups. 
Conclusions: - Atherogenic diet produced increase in 
body weight of rabbits. Less weight gain was seen in 
rabbits on atherogenic diet with niacin supplementation. 
Marked response to reduction in body weight was 
observed in rabbits with cholesterol restriction and niacin 
supplementation. 
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Introduction 
    Atherosclerotic disease is projected to become the 
leading cause of global morbidity and mortality by 
2020.1 Cardiovascular disease (CVD) is a major global 
health problem reaching epidemic proportions in 
middle income countries including South Asian 
countries (Pakistan and India).2 A cross-sectional 
descriptive study carried out at Aga Khan University 
Hospital (a teaching hospital) in Karachi, among 370 
ambulatory Pakistani adults (18-60 years),showed  the 
populations of major risk factors for CAD were 
sedentary life style(72%), family history(42%), 
dyslipidemia(31%), obesity(24%),hypertension(19%) 
and diabetes mellitus(15%).Non quantified risks with 
weak association include obesity, type A personality, 
post-menopausal estrogen deficiency, contraceptive 
pills, high carbohydrate intake, lack of exercise, 
hardened unsaturated fat intake, heavy alcohol 
consumption and chlamydia pneumonia.3 
     With drugs like Statin, risk of CVD can be reduced 
by about 30%.4 Newer drugs are being researched and 
introduced in the treatment of hyperlipidemia in 
humans. Niacin has been used for many years to treat 
hyperlipidemia and shown to reduce coronary death.5 
Investigations have shown that combining Statin 
therapy with Niacin results in additive improvement 
in the major lipids and lipoproteins and thus improve 
clinical out-come.6 Niacin lowers concentration of all 
atherogenic plasma lipids and at the same time raises 
the level of protective HDL-C.7,8 The pharmacological 
dosage (0.5-4.5 gm/day) influences the plasma lipids 
and lipoprotein concentration.9 
 
Materials and Methods 
    This study was an experimental randomized control 
trial conducted at Army Medical College, Rawalpindi. 
Forty adult male New Zealand White rabbits (4-6 
months age) were used for this study. All were kept 
under controlled temperature at 21 ± 2oC, on a 12-hour 
light/12-hour dark cycle and allowed to acclimatize 
for two weeks in animal house at NIH, Islamabad. All 
animals were initially fed rabbit concentrated diet 
prepared at NIH and water ad libitum. The amount of 
diet was recorded and restricted to 130 gm/day 
during entire study. The animals were randomly 
divided into four groups each comprising ten rabbits. 
Group A served as pure control and received standard 
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animal house diet for 2 months. Group B served as 
treated control and received atherogenic diet 
(concentrated diet + 0.5 % cholesterol) for 2 months. 
Group C an experimental group was given Niacin in a 
dose of 15 mg/kg b.w mixed in atherogenic diet for 2 
months. Group D was an experimental group received 
atherogenic diet for 2 months and these rabbits were 
shifted to routine animal house diet with Niacin for 
another 2 months. Animals were weighed at the start 
of experiment and at the time of sacrifice. Mean scores 
were calculated and results were analyzed using SPSS 
version 15. Statistical analysis was performed using 
ANOVA for comparison of four groups. Difference 
among the groups was regarded statistically 
significant at p<0.05. 
  
Results 
    General condition of all animals was observed and 
weight recorded at the start of experiment and before 
the sacrifice of rabbits. The mean initial body weight 
(Wi) of rabbits in Group A, B, C and D was 
1.875±0.094, 1.670±0.067, 1.660±0.085 and 1.805±0.038 
kg respectively (Table 1). The mean final body weight 
(Wf) of rabbits in Group A, B, C and D was 
1.850±0.099, 1.920±0.046, 1.695±0.069 and 1.745±0.052 
kg respectively (Table 1). Mean change in body weight 
in Group A was 0.025±0.03 kg decreased (Fig. 1). The 
difference between the mean body weight found 
statistically highly significant (p=0.001) in Group B 
rabbits and mean change in body weight in this group 
was 0.250±0.052 kg increased (Fig. 1).  Post Hoc test 
using Least Significant Difference (LSD) showed 
statistically significant difference (p=0.002), when this 
weight change was compared with pure control group 
A (Table 2). Mean change in body weight in 
Experimental Group C was 0.0.035±0.086 kg increased 
(Fig. 1). Statistically this weight change compared with 
Group B, difference was found significant (p=0.014) 
but insignificant with group A (p=0.474) (Table 
2).Mean change in body weight of rabbits in 
Experimental Group D was 0.060±0.050 kg decreased 
(Fig. 1). Statistically when this weight change was 
compared with Group B, significant difference was  
found (P=0.001) but was insignificant with group A 
(P=0.675) and group C (P=0.259) (Table 2). 
 
Discussion 
     Pure Control GroupA rabbits (fed on standard 
animal house diet) were weighed in the beginning and 
at the end of experiment 1.875±0.094 kg and 
1.850±0.099 kg respectively. Statistically no difference 
was found with respect to the weight gain. These 
results were similar to the one for control group NZW 
rabbits in a study conducted by Quileset al. to see the 
effects of curcuma longa extract on aortic fatty streak 
development.10 This finding is also in accordance with 
findings of control groups observed by Sekalska et al  
Table 1: Body weight of rabbits in control 
and experimental groups* 
Group 
Body Weight(W) Kg 
p- value Initial (Wi) 
Mean ± S.E 
Final (Wf) 
Mean ± S.E 
A 1.875 ± 0.094 1.850 ± 0.099 0.427 
B 1.670 ± 0.067 1.920 ± 0.046 0.001 
C 1.660 ± 0.085 1.695 ± 0.069 0.696 
D 1.805 ± 0.036 1.745 ± 0.052 0.269 
*Group A Pure Control (Standard animal house diet 2 months); 
Group B Treated Control (Atherogenic diet 2 months);  
Group C Experimental Group (Atherogenic diet + Niacin 2months); 
Group D Experimental Group (Atherogenic diet 2 months followed 
by standard animal house diet + Niacin 2 months) 
Table 2:Comparison of body weight change in 
rabbits (control and experimental groups)* 
Group p-value 
A v B 0.002 
A v C 0.474 
A v D 0.675 
B v C 0.014 
B v D 0.001 
C v D 0.259 
*Group A  Pure Control (Standard animal house diet 2 months); 
Group B Treated Control (Atherogenic diet 2 months);  
Group C Experimental Group (Atherogenic diet + Niacin 2 
months); Group D Experimental Group (Atherogenic diet 2months 
followed by standard animal house diet + Niacin 2  months)   
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Fig 1: Change in weight (W) among the groups of 
Rabbits. 
 
in their study on Ibuprofen effects on the development 
of fat induced atherosclerosis in NZW rabbits. 11 
  Treated Control Group B rabbits (fed on atherogenic 
diet) weighed before start and at the end of 
experiment were 1.670±0.067 kg and 1.920±0.046 kg 
respectively. Results showed significant increase in 
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mean body weight 0.250±0.052 kg in these animals. 
Similar findings were observed by Sekalskaet al in 
their study on NZW rabbits fed on atherogenic diet. 1 
When comparison of mean body weight was done 
within group, no difference was found statistically 
with respect to the weight gain at end of experimental 
time. This finding is in accordance with Quiles et al 
who also found no difference among the experimental 
groups with respect to weight gain in NZW rabbits fed 
on atherogenic diet. 10 
    Experimental Group C rabbits (fed on atherogenic 
diet + Niacin 15 mg/kg b.w) weighed before start as 
Wi1.660±0.085 kg and at the end of 2 months of 
experimental duration as Wf1.695±0.069 kg. 
Statistically the difference between weight gain was 
insignificant within the group and among the groups. 
This finding is in accordance with results seen in a 
study on Ibuprofen in NZW rabbits (on atherogenic 
diet) conducted by Sekelska et al..11 
    In the beginning of present study Experimental 
Group D animals were weighed as Wi 1.805±0.038 kg 
and at the end of experiment after four months as Wf 
1.745±0.052 kg. Thus statistically mean change in body 
weight was decreased 0.060±0.050 kg (Fig. 1). This 
reduction in weight could be due to the restriction of 
cholesterol in the diet and supplementation of Niacin 
as seen in group C. This finding is contrary to one seen 
by Jeremy et al in a study conducted on NZW rabbits 
for atherosclerosis, where rabbits in each treatment 
group gained weight with an average gain of 4% of 
base line after seven weeks supplementation of L-
Arginine. 12 Weight reduction in the present study in 
this group is in accordance with description given by 
Grundy , that weight reduction in people helps to keep 
serum LDL-C level at a lower range. 13 
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